Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Michael G. Haddock

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8966-744X; OpenAlex author ID A5071942279. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 1, last author 0)
Trials
1
Grants
0
Labs led
0
Collaborators
56
Papers, trials and grants by year

2001: 1 trial · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 10

  1. High SMAD4 Expression is Associated With Improved Clinical Outcomes in Patients With Resectable Pancreatic Cancer: An Analysis of NRG Oncology/RTOG 9704. Co-author DOI 10.1016/j.ijrobp.2026.09.014↗
  2. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in th… Co-author DOI 10.1016/j.ijrobp.2023.08.009↗
  3. N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyac002↗
  4. FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.6004/jnccn.2022.7041↗
  5. Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institu… Co-author DOI 10.1097/mpa.0000000000001822↗
  6. Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review. Co-author DOI 10.1097/mpa.0000000000001566↗
  7. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704. Co-author DOI 10.1634/theoncologist.2019-0562↗
  8. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1016/j.gie.2016.11.014↗
  9. Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. First author DOI 10.1016/j.ijrobp.2015.11.003↗
  10. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent… Co-author DOI 10.1097/coc.0b013e3181f946fc↗

Trials 1

  1. Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer Study chair NCT00026403↗

Closest collaborators

The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher Leigh Hallemeier · 6 shared papers, 2011–2024 · strength 0.65
  2. Kenneth Wing Merrell · 3 shared papers, 2016–2024 · strength 0.38
  3. William F. Regine · 2 shared papers, 2020–2026 · strength 0.32
  4. Edgar Ben‐Josef · 2 shared papers, 2020–2026 · strength 0.32
  5. Thorvardur Ragnar Halfdanarson · 2 shared papers, 2022 · strength 0.29
  6. Michael L. Kendrick · 3 shared papers, 2016–2022 · strength 0.25
  7. Steven R. Alberts · 2 shared papers, 2017–2022 · strength 0.24
  8. Hyun Kim · 1 shared paper, 2026 · strength 0.24
  9. Chandan Guha · 1 shared paper, 2026 · strength 0.24
  10. Ryan N. Robb · 1 shared paper, 2026 · strength 0.24
  11. Terence Marques Williams · 1 shared paper, 2026 · strength 0.24
  12. Lauren E. Henke · 1 shared paper, 2026 · strength 0.24
  13. Isabella Zaniletti · 1 shared paper, 2024 · strength 0.20
  14. Todd A. DeWees · 1 shared paper, 2024 · strength 0.20
  15. George P. Kim · 1 shared paper, 2022 · strength 0.17
  16. Chris J Beltran · 1 shared paper, 2020 · strength 0.12
  17. Timothy Dean Malouff · 1 shared paper, 2020 · strength 0.12
  18. Sunil Krishnan · 1 shared paper, 2020 · strength 0.12
  19. Bradford S. Hoppe · 1 shared paper, 2020 · strength 0.12
  20. Daniel Michael Trifiletti · 1 shared paper, 2020 · strength 0.12
  21. Amro M. Abdelrahman · 1 shared paper, 2022 · strength 0.12
  22. Jennifer A. Yonkus · 1 shared paper, 2022 · strength 0.12
  23. Sean Patrick Cleary · 1 shared paper, 2022 · strength 0.12
  24. Jennifer L. Leiting · 1 shared paper, 2022 · strength 0.12
  25. Nguyen H. Tran · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.